Authors
Latest:
Leveraging Technology for Pharmaceutical CommercializationWith AI/ML and cognitive technologies set to become a key enabler of the pharma commercialization process, Srini Rajamani outlines how pharma companies can leverage tech effectively.
Latest:
How to Conduct More Impactful Patient and Caregiver Advisory BoardsLooking to hold an advisory board? Here are a few suggestions.
Latest:
Three Ways to Close the Urgent Talent GapThe industry has struggled to recruit talent for years, and the challenge is only getting more difficult. Pharma companies need to recruit differently.
Latest:
Patient Experience Breakthroughs: Leveraging the Latest Digital Tools and Techniques to Optimize your Patient Experience GoalsLearn how breakthrough patient experience strategies can help achieve your study goals in this upcoming webcast. Lead by renowned neuroscientist and behavioral economist Dr. Paul Glimcher, it’s the one webcast this year your team can’t afford to miss. Live: Tuesday, May 19, 2020 at 1pm EDT | 12pm CDT | 10am PDT On demand available after airing until May 19, 2021.
Latest:
Recruiting and Retaining Talent Is the Biggest Challenge Facing the Pharmaceutical IndustryRecent increases in employee burnout and turnover must be addressed.
Latest:
Making an Impact in the Era of DisinformationWith increasing cases of disinformation across social media blurring the lines of what’s credible and real, how can pharma break through the noise and build back public trust?
Latest:
Flip the ScriptLife sciences transformations rarely fail because of what was in the plan. They fail because of what was not. Explore five trends that will determine their success in coming years.
Latest:
The Challenges of Worker Qualification Management in PharmaLife sciences companies uniquely tasked with meeting continuous and complex compliance-reporting requirements.
Latest:
A Generational Opportunity for Talent Pipeline DevelopmentCOVID-19 creates a unique chance to refocus STEM strategies.
Latest:
How to Connect with HCPs More EffectivelyRegardless of engagement mode pursued, personalization is the key.
Latest:
Recruitment Lessons from the COVID-19 PandemicFiona Huzarski outlines four key recruitment lessons that pharma can take from the coronavirus crisis and use to move forward and thrive.
Latest:
Crisis Communication Plans in PharmaThe pharmaceutical industry must have crisis communications prepared now to anticipate unforeseen events—especially those that impact public trust.
Latest:
Clues on Equity Engagement LevelsA survey of 18 biopharmas, measuring their scope and implementation across key health equity dimensions and activities, uncovers useful context as companies seek better alignment of these goals with overall strategy.
Latest:
Restoring Hope in Mental Illness Is a Collective MissionThe importance of equitable approaches to diagnosis and treatment.
Latest:
The Promise and Peril of AI in the Physical WorldThe use of artificial intelligence (AI) in drug development has been hampered by issues that have caused a gap between AI’s potential and its full utilization in this space.
Latest:
Action Through Engagement: Alleviating COVID Concerns in Patients with Underlying ConditionsIt’s important that care for people with pre-existing conditions or at risk from serious diseases does not fall by the wayside.
Latest:
Better Supply Chains Can Better Tackle Threats to Public HealthTo effectively combat the looming threat of antimicrobial resistance, we must prioritize working together to strengthen and more responsibly manage global supply chains.
Latest:
From Concept to Commercialization: Pushing the EnvelopeDisruptive strategies are essential to grow the pharma industry.
Latest:
Environmental Sustainability in the Life Sciences Sector: Embedding ChangeFor many years, high energy use and its impact on the environment by businesses within the life sciences sector had been generally overlooked in national and global efforts to combat climate change. But with “carbon neutrality” the new buzzwords, how is the sector embracing this push for change?
Latest:
Powering Pipelines Forward: Approach Science DifferentlyWhy tapping the value generated for the next set of therapies is critical.
Latest:
Exploring Biopharma's Dealmaking Terrain, Roadmap in ChinaA surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.
Latest:
Paving the Path to IPO: How to Build Compliant Financial Systems and ProcessesThursday, April 28, 2022 at 11am PDT | 2pm EDT Are you ready for the challenges of going public? Whether you are a fast-growing biotech company or are currently public and looking for SOX compliance, this webinar will cover how to set up scalable and compliant financial processes.
Latest:
The Future of Obesity Pharmacology: Bridging Evidence Gaps with a New Model for Clinical RegistriesThe challenges in obesity research are significant, but the opportunities for innovation are equally profound.
